EGF1 48
Alternative Names: EGF1-48Latest Information Update: 06 May 2024
At a glance
- Originator Cresence
- Class Anti-inflammatories; Neuropeptides; Neuroprotectants
- Mechanism of Action Myelin protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurodegenerative disorders